The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension

Chronic thromboembolic pulmonary hypertension (CTEPH) is currently underdiagnosis and consequently undertreatment in the clinical practice. A deficient in diagnostic modality and treatment availability especially in developing countries makes the CTEPH diagnosis unlikely to confirm. However, high in...

Full description

Bibliographic Details
Main Authors:	Anggoro Budi Hartopo, Lucida Kris Dinarti, Abdul S Wahab
Format:	Article
Language:	English
Published:	Interna Publishing 2017-04-01
Series:	Acta Medica Indonesiana
Subjects:	chronic thromboembolic pulmonary hypertension diagnosis pulmonary hypertension
Online Access:	http://www.actamedindones.org/index.php/ijim/article/view/235

id	doaj-036b125d4d8448a287df799b325f7444
record_format	Article
spelling	doaj-036b125d4d8448a287df799b325f74442020-11-24T21:17:14ZengInterna PublishingActa Medica Indonesiana0125-93262338-27322017-04-01492206The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary HypertensionAnggoro Budi Hartopo0Lucida Kris Dinarti1Abdul S Wahab2Division of Cardiology, Department of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada – Sardjito Hospital, Yogyakarta, IndonesiaDepartment of Internal Medicine, Faculty of Medicine Universitas Gadjah Mada – Sardjito Hospital, Yogyakarta, IndonesiaDepartment of Child Health, Faculty of Medicine Universitas Gadjah Mada – Sardjito Hospital, Yogyakarta, IndonesiaChronic thromboembolic pulmonary hypertension (CTEPH) is currently underdiagnosis and consequently undertreatment in the clinical practice. A deficient in diagnostic modality and treatment availability especially in developing countries makes the CTEPH diagnosis unlikely to confirm. However, high index of clinical suspicion of CTEPH will lead to proper diagnosis and correct treatment with significant reduction in morbidity and mortality. Left untreated, the mean survival time is 6.8 years and the three year mortality rate may be as high as 90 %. The pathophysiology, diagnosis and treatment of CTEPH are necessary to be shared among internists and primary care physicians, in order to improve the overall outcome of the patients.http://www.actamedindones.org/index.php/ijim/article/view/235chronic thromboembolic pulmonary hypertensiondiagnosispulmonary hypertension
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Anggoro Budi Hartopo Lucida Kris Dinarti Abdul S Wahab
spellingShingle	Anggoro Budi Hartopo Lucida Kris Dinarti Abdul S Wahab The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension Acta Medica Indonesiana chronic thromboembolic pulmonary hypertension diagnosis pulmonary hypertension
author_facet	Anggoro Budi Hartopo Lucida Kris Dinarti Abdul S Wahab
author_sort	Anggoro Budi Hartopo
title	The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
title_short	The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
title_full	The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
title_fullStr	The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
title_full_unstemmed	The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension
title_sort	challenge in diagnosis and current treatment of chronic thromboembolic pulmonary hypertension
publisher	Interna Publishing
series	Acta Medica Indonesiana
issn	0125-9326 2338-2732
publishDate	2017-04-01
description	Chronic thromboembolic pulmonary hypertension (CTEPH) is currently underdiagnosis and consequently undertreatment in the clinical practice. A deficient in diagnostic modality and treatment availability especially in developing countries makes the CTEPH diagnosis unlikely to confirm. However, high index of clinical suspicion of CTEPH will lead to proper diagnosis and correct treatment with significant reduction in morbidity and mortality. Left untreated, the mean survival time is 6.8 years and the three year mortality rate may be as high as 90 %. The pathophysiology, diagnosis and treatment of CTEPH are necessary to be shared among internists and primary care physicians, in order to improve the overall outcome of the patients.
topic	chronic thromboembolic pulmonary hypertension diagnosis pulmonary hypertension
url	http://www.actamedindones.org/index.php/ijim/article/view/235
work_keys_str_mv	AT anggorobudihartopo thechallengeindiagnosisandcurrenttreatmentofchronicthromboembolicpulmonaryhypertension AT lucidakrisdinarti thechallengeindiagnosisandcurrenttreatmentofchronicthromboembolicpulmonaryhypertension AT abdulswahab thechallengeindiagnosisandcurrenttreatmentofchronicthromboembolicpulmonaryhypertension AT anggorobudihartopo challengeindiagnosisandcurrenttreatmentofchronicthromboembolicpulmonaryhypertension AT lucidakrisdinarti challengeindiagnosisandcurrenttreatmentofchronicthromboembolicpulmonaryhypertension AT abdulswahab challengeindiagnosisandcurrenttreatmentofchronicthromboembolicpulmonaryhypertension
_version_	1726013372541960192

The Challenge in Diagnosis and Current Treatment of Chronic Thromboembolic Pulmonary Hypertension

Similar Items